Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Butters, T, Dwek, R, Platt, F
Μορφή:	Conference item
Έκδοση:	2005

Παρόμοια τεκμήρια

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
ανά: Butters, T, κ.ά.
Έκδοση: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
ανά: Platt, F, κ.ά.
Έκδοση: (2003)

Iminosugars and methods of treating Arenaviral infections
ανά: Ramstedt, U, κ.ά.
Έκδοση: (2010)

Iminosugars and methods of treating viral diseases
ανά: Ramstedt, U, κ.ά.
Έκδοση: (2011)

Iminosugars and methods of treating Filoviral diseases
ανά: Ramstedt, U, κ.ά.
Έκδοση: (2011)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
ανά: Ramstedt, U, κ.ά.
Έκδοση: (2010)

Storage solutions: treating lysosomal disorders of the brain.
ανά: Jeyakumar, M, κ.ά.
Έκδοση: (2005)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
ανά: Norris-Cervetto, E, κ.ά.
Έκδοση: (2006)

Therapeutic applications of imino sugars in lysosomal storage disorders.
ανά: Butters, T, κ.ά.
Έκδοση: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
ανά: Butters, T, κ.ά.
Έκδοση: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
ανά: Butters, T, κ.ά.
Έκδοση: (2000)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
ανά: Jeyakumar, M, κ.ά.
Έκδοση: (2002)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
ανά: Butters, T, κ.ά.
Έκδοση: (2003)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
ανά: Boucheron, C, κ.ά.
Έκδοση: (2005)

Iminosugar for treatment of tumors
ανά: Dwek, R, κ.ά.
Έκδοση: (2008)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
ανά: Durantel, D, κ.ά.
Έκδοση: (2001)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
ανά: Boomkamp, S, κ.ά.
Έκδοση: (2010)

Iminosugar antivirals: the therapeutic sweet spot
ανά: Alonzi, D, κ.ά.
Έκδοση: (2017)

Assessment of Target Engagement in a First‐in‐Human Trial with Sinbaglustat, an Iminosugar to Treat Lysosomal Storage Disorders
ανά: Martine Gehin, κ.ά.
Έκδοση: (2021-03-01)

Use of iminosugar derivatives to inhibit ion channel activity
ανά: Zitzmann, N, κ.ά.
Έκδοση: (2004)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
ανά: Priestman, D, κ.ά.
Έκδοση: (2008)

Antiviral effects of an iminosugar derivative on flavivirus infections.
ανά: Wu, S, κ.ά.
Έκδοση: (2002)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
ανά: Boucheron, C, κ.ά.
Έκδοση: (2005)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
ανά: Platt, F, κ.ά.
Έκδοση: (2000)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
ανά: Andersson, U, κ.ά.
Έκδοση: (2000)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
ανά: Steinmann, E, κ.ά.
Έκδοση: (2007)

New developments in treating glycosphingolipid storage diseases.
ανά: Platt, F, κ.ά.
Έκδοση: (2005)

<i>N</i>-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase
ανά: Andreas Wolfsgruber, κ.ά.
Έκδοση: (2020-10-01)

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
ανά: Kelly L. Warfield, κ.ά.
Έκδοση: (2015-05-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
ανά: Silk, J, κ.ά.
Έκδοση: (2005)

Treating lysosomal storage disorders: current practice and future prospects.
ανά: Platt, F, κ.ά.
Έκδοση: (2009)

Long alkylchain iminosugars block the HCV p7 ion channel
ανά: Pavlovic, D, κ.ά.
Έκδοση: (2005)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
ανά: Gadola, S, κ.ά.
Έκδοση: (2006)

Erratum: Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease (Tetrahedron: Asymmetry (2005) 16 (1747) DOI: 10.1016/j.tetasy.2005.03. 015)
ανά: Boucheron, C, κ.ά.
Έκδοση: (2005)

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.
ανά: Miller, J, κ.ά.
Έκδοση: (2012)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors
ανά: Kato, A, κ.ά.
Έκδοση: (2015)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors.
ανά: Kato, A, κ.ά.
Έκδοση: (2015)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
ανά: Désiré, J, κ.ά.
Έκδοση: (2014)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence
ανά: Priestman, D, κ.ά.
Έκδοση: (2017)

The mechanism of action of iminosugars as antiretrovirals
ανά: Spiro, S, κ.ά.
Έκδοση: (2014)